Motif ID: Zbtb7a
Z-value: 0.926
Transcription factors associated with Zbtb7a:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Zbtb7a | ENSMUSG00000035011.9 | Zbtb7a |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Zbtb7a | mm10_v2_chr10_+_81136223_81136271 | -0.15 | 2.3e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 7.6 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 1.8 | 7.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.6 | 6.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 1.6 | 6.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 1.5 | 4.6 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
| 1.4 | 4.2 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
| 1.3 | 5.3 | GO:1903802 | positive regulation of arachidonic acid secretion(GO:0090238) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 1.2 | 3.7 | GO:1900673 | olefin metabolic process(GO:1900673) |
| 1.1 | 3.4 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) |
| 1.1 | 2.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 1.1 | 3.2 | GO:1904742 | protein poly-ADP-ribosylation(GO:0070212) regulation of telomeric DNA binding(GO:1904742) |
| 1.1 | 3.2 | GO:0071336 | lung growth(GO:0060437) positive regulation of fat cell proliferation(GO:0070346) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 1.0 | 5.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.9 | 5.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.9 | 5.5 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.9 | 1.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.9 | 4.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
| 0.9 | 3.4 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.8 | 4.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.8 | 1.7 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.8 | 2.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.8 | 3.2 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.8 | 3.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
| 0.7 | 3.6 | GO:0051012 | microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.7 | 2.6 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.6 | 5.8 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.6 | 1.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.6 | 4.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 | 1.9 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
| 0.6 | 2.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.5 | 1.6 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.5 | 1.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.5 | 6.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.5 | 1.5 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.5 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 | 1.3 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.4 | 3.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.4 | 6.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.4 | 3.9 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
| 0.4 | 2.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.4 | 1.2 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.4 | 1.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.4 | 1.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.4 | 1.2 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.4 | 1.6 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.4 | 1.2 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.4 | 1.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.4 | 9.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 | 1.1 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.4 | 5.0 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.4 | 3.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.4 | 1.1 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 | 2.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 | 3.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.3 | 3.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.3 | 3.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.3 | 2.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 | 2.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 | 1.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.3 | 3.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.3 | 1.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.3 | 1.6 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.3 | 2.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.3 | 1.0 | GO:1901660 | calcium ion export(GO:1901660) |
| 0.2 | 1.5 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.2 | 1.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.2 | 3.6 | GO:1900120 | regulation of receptor binding(GO:1900120) |
| 0.2 | 2.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 | 1.4 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 | 3.7 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.2 | 1.4 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.2 | 6.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.2 | 0.6 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 0.2 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 2.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.2 | 1.4 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.2 | 1.2 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 | 0.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 1.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.2 | 0.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 | 0.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.2 | 1.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.2 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 0.2 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 | 0.4 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
| 0.1 | 3.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 | 1.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 1.4 | GO:0033280 | response to vitamin D(GO:0033280) |
| 0.1 | 4.9 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 | 2.6 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 | 2.1 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 | 0.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.7 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.1 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 3.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
| 0.1 | 2.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 | 0.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 1.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 1.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.1 | 6.5 | GO:0015807 | L-amino acid transport(GO:0015807) |
| 0.1 | 0.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 0.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.1 | 0.5 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.1 | 0.7 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.1 | 0.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.1 | 0.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.1 | 3.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.1 | 1.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 | 0.4 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 | 0.3 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 | 4.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.1 | 0.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 | 1.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 3.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.1 | 1.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.1 | 1.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.1 | 7.9 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 | 0.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 0.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 | 1.2 | GO:0021756 | striatum development(GO:0021756) |
| 0.1 | 0.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 1.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 0.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 | 1.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.1 | 1.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 1.7 | GO:0046856 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 1.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.1 | 0.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 | 1.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.1 | 1.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.1 | 0.6 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 | 0.2 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.1 | 0.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.1 | 0.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.1 | 0.8 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 | 1.8 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 | 0.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 | 0.5 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 1.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 1.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.1 | 0.6 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
| 0.1 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 4.1 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 | 1.5 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 | 0.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 | 0.3 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 | 0.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.1 | 0.9 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 1.0 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
| 0.1 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.1 | 0.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 | 2.2 | GO:0007416 | synapse assembly(GO:0007416) |
| 0.1 | 0.8 | GO:0033198 | response to ATP(GO:0033198) |
| 0.1 | 3.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 0.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 0.1 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.1 | 0.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.0 | 1.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.8 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.0 | 1.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 0.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 | 2.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.0 | 0.8 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.0 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.0 | 0.7 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.0 | 0.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.2 | GO:0050689 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 | 0.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.0 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 0.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 | 1.7 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 | 0.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 1.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 | 1.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 | 2.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.0 | 0.1 | GO:0090244 | dorsal/ventral axis specification(GO:0009950) Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 | 0.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 | 1.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.0 | 0.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 2.2 | GO:0006821 | chloride transport(GO:0006821) |
| 0.0 | 2.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.0 | 2.8 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
| 0.0 | 0.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 1.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 | 1.2 | GO:0050905 | neuromuscular process(GO:0050905) |
| 0.0 | 1.3 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.0 | 0.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.0 | 1.4 | GO:0031638 | zymogen activation(GO:0031638) |
| 0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.8 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.0 | 0.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.0 | 0.0 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 2.4 | GO:0051297 | centrosome organization(GO:0051297) |
| 0.0 | 0.9 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
| 0.0 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.0 | 4.0 | GO:0007411 | axon guidance(GO:0007411) |
| 0.0 | 1.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.3 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.0 | 3.0 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.0 | 1.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.0 | 0.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.0 | 0.2 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 1.4 | GO:0007623 | circadian rhythm(GO:0007623) |
| 0.0 | 0.6 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
| 0.0 | 0.6 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 0.0 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
| 0.0 | 0.4 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
| 0.0 | 0.6 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.0 | 0.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 2.3 | GO:0050890 | cognition(GO:0050890) |
| 0.0 | 1.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 | 0.3 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
| 0.0 | 0.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 5.3 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.9 | 3.7 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.9 | 5.1 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.7 | 2.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.5 | 4.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.4 | 1.2 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.4 | 4.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.3 | 5.4 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
| 0.3 | 5.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.3 | 3.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.3 | 1.0 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.3 | 3.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.3 | 2.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.3 | 3.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 2.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.3 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 5.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.2 | 1.7 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.2 | 3.5 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 9.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 1.3 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 4.8 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 0.2 | 3.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.2 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.2 | 0.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.2 | 1.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 7.8 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 2.1 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 1.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 11.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 1.2 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.1 | 8.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 1.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 2.2 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.1 | 4.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 2.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 2.6 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 10.8 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 6.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 3.1 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.1 | 0.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
| 0.1 | 0.7 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 4.5 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 1.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.7 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 0.1 | 16.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 0.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.0 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.0 | 0.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 1.4 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 1.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 1.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.6 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.0 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.0 | 2.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.8 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 4.1 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 2.0 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.0 | 1.2 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.1 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
| 0.0 | 1.8 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
| 0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 5.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 3.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 0.9 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 1.0 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 0.5 | GO:0009986 | cell surface(GO:0009986) |
| 0.0 | 0.6 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 8.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 1.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 1.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.0 | 1.9 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.6 | GO:0030496 | midbody(GO:0030496) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 5.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 1.1 | 3.4 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
| 1.0 | 6.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 1.0 | 2.9 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
| 0.9 | 3.5 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
| 0.8 | 3.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.8 | 2.3 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.8 | 3.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.7 | 5.7 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.6 | 2.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.6 | 1.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.6 | 11.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.6 | 4.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.6 | 1.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.6 | 7.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.5 | 1.6 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) epinephrine binding(GO:0051379) |
| 0.5 | 2.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.5 | 3.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 0.5 | 7.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.5 | 4.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.5 | 1.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.4 | 1.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.4 | 1.7 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.4 | 5.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.4 | 1.6 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
| 0.4 | 3.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.4 | 1.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) dinucleotide insertion or deletion binding(GO:0032139) single guanine insertion binding(GO:0032142) |
| 0.4 | 5.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.4 | 14.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.3 | 6.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.3 | 1.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.3 | 3.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.3 | 3.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.3 | 3.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 1.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.3 | 0.6 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.3 | 4.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.3 | 7.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.3 | 2.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.3 | 1.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.3 | 2.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.3 | 1.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.3 | 1.5 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.3 | 6.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.3 | 3.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.3 | 2.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.3 | 9.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 6.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 1.4 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 0.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) tubulin deacetylase activity(GO:0042903) |
| 0.2 | 1.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.2 | 1.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.2 | 1.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
| 0.2 | 1.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.2 | 0.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.2 | 4.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
| 0.2 | 1.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.2 | 0.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.2 | 0.6 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.1 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 2.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 5.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.1 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 1.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.1 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 1.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
| 0.1 | 1.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
| 0.1 | 2.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 2.0 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 0.7 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.1 | 0.7 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 1.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.3 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 0.1 | 2.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 0.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.1 | 4.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 4.2 | GO:0008748 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
| 0.1 | 0.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.1 | 0.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 1.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.1 | 7.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 2.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 0.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 1.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 5.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.6 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 3.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.1 | 2.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 1.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.1 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 1.2 | GO:0042556 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 1.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 1.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
| 0.1 | 0.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 5.9 | GO:0043851 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) rRNA (uridine-2'-O-)-methyltransferase activity(GO:0008650) rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) selenocysteine methyltransferase activity(GO:0016205) rRNA (adenine) methyltransferase activity(GO:0016433) rRNA (cytosine) methyltransferase activity(GO:0016434) rRNA (guanine) methyltransferase activity(GO:0016435) 1-phenanthrol methyltransferase activity(GO:0018707) protein-arginine N5-methyltransferase activity(GO:0019702) dimethylarsinite methyltransferase activity(GO:0034541) 4,5-dihydroxybenzo(a)pyrene methyltransferase activity(GO:0034807) 1-hydroxypyrene methyltransferase activity(GO:0034931) 1-hydroxy-6-methoxypyrene methyltransferase activity(GO:0034933) demethylmenaquinone methyltransferase activity(GO:0043770) cobalt-precorrin-6B C5-methyltransferase activity(GO:0043776) cobalt-precorrin-7 C15-methyltransferase activity(GO:0043777) cobalt-precorrin-5B C1-methyltransferase activity(GO:0043780) cobalt-precorrin-3 C17-methyltransferase activity(GO:0043782) dimethylamine methyltransferase activity(GO:0043791) hydroxyneurosporene-O-methyltransferase activity(GO:0043803) tRNA (adenine-57, 58-N(1)-) methyltransferase activity(GO:0043827) methylamine-specific methylcobalamin:coenzyme M methyltransferase activity(GO:0043833) trimethylamine methyltransferase activity(GO:0043834) methanol-specific methylcobalamin:coenzyme M methyltransferase activity(GO:0043851) monomethylamine methyltransferase activity(GO:0043852) P-methyltransferase activity(GO:0051994) Se-methyltransferase activity(GO:0051995) 2-phytyl-1,4-naphthoquinone methyltransferase activity(GO:0052624) tRNA (uracil-2'-O-)-methyltransferase activity(GO:0052665) tRNA (cytosine-2'-O-)-methyltransferase activity(GO:0052666) phosphomethylethanolamine N-methyltransferase activity(GO:0052667) tRNA (cytosine-3-)-methyltransferase activity(GO:0052735) rRNA (cytosine-2'-O-)-methyltransferase activity(GO:0070677) rRNA (cytosine-N4-)-methyltransferase activity(GO:0071424) trihydroxyferuloyl spermidine O-methyltransferase activity(GO:0080012) |
| 0.1 | 2.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.1 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 2.7 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
| 0.1 | 2.3 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
| 0.1 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 1.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 1.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.1 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.0 | 1.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 1.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 10.9 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
| 0.0 | 1.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.0 | 1.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.0 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
| 0.0 | 8.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.0 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.0 | 0.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.0 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 1.8 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 2.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 2.3 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.8 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.8 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.0 | 2.9 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.0 | 0.6 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.0 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
| 0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.0 | 0.5 | GO:0019239 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) deaminase activity(GO:0019239) |
| 0.0 | 0.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 1.3 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 3.5 | GO:0043774 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
| 0.0 | 0.5 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
